期刊文献+

脂多糖——针对革兰阴性菌的药物靶标 被引量:6

Lipopolysaccharide--a Target for the Development of Novel Drugs Being Aimed at Gram-Negative Bacteria
原文传递
导出
摘要 革兰阴性菌细胞外膜成分脂多糖对于维持细菌的结构完整性非常重要。脂多糖被称为内毒素,是革兰阴性菌致病的物质基础。脂多糖由三部分组成,包括O-特异多糖、核心多糖和类脂A,类脂A是脂多糖的毒性中心。脂多糖可导致机体发生严重感染,引起局部或全身性病理生理反应。脂多糖的毒性作用是通过其介导的信号途径导致机体产生强烈免疫应答引起的。目前,对于脂多糖信号通路中的相关蛋白及受体的研究已取得了一定的进展。本文综述了脂多糖及其所介导信号通路中主要相关蛋白及受体的研究现状。 Lipopolysaccharide (LPS), the important component of the outer membrane of Gram-negative bacteria, contributes to the integrity of the outer membrane, and protects the cell against bactericidal agents. LPS, also called endotoxin synonymously, is well known as a potent inducer of the innate immune system that often causes septic shock in the intensive cares. Chemically, the amphiphilic LPS is made up of three parts, i.e. hydrophobic lipid A, hydrophilic core oligosaccharide chain, and hydrophilic O-antigenic polysaccharide side chain. Specially, the lipid A is known to be responsible for a variety of biological effects during Gram-negative sepsis. LPS can elicit a strong response from innate immune system and result in local or systemic adverse reactions. LPS can trigger massive inflam- matory responses and may result in immunopathology, for which the molecular basis is mediated by the signal path way of LPS. In recent years, a tremendous progress has been made in determining the associated proteins and recep tors in the LPS signaling that leads to the disease. This review gives a summary of recent progresses of research on LPS and LPS receptors.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2015年第4期910-913,共4页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(21372222)
关键词 脂多糖 脂多糖信号通路 脂多糖结合蛋白 脂多糖受体 lipopolysaccharide lipopolysaccharide signal transduction lipopolysaccharide-binding protein lipopolysaccharide receptors
  • 相关文献

参考文献36

  • 1BRUEGEL M, LUDWIG U, KLEINHEMPEL A, et al. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients [J]. Crit Care Med, 2012, 40(5): 1478-1486. 被引量:1
  • 2GENTILE L F, CUENCA A G, VANZANT E L, et al. Isthere value in plasma cytokine measurements in patients with severe trauma and sepsis? [J]. Methods, 2013, 61(1): 3-9. 被引量:1
  • 3SCHULTE W, BERNHAGEN J, BUCALA R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view [J].Mediators Inflamm, 2013, 2013: 165974. 被引量:1
  • 4DING P H, JIN L J. The protein in innate immunity: role of lipopolysaccharide-binding a revisit and its relevance to oral/ periodontal health [J]. J Periodontal Res, 2014, 49(1) : 1-9. 被引量:1
  • 5KAGAN J C. Immunology. Sensing endotoxins from within [J]. Science, 2013, 341(6165).. 1184-1185. 被引量:1
  • 6NEEDHAM B D, TRENT M S. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis [J].Nat Rev Microbiol, 2013, 11(7): 467-481. 被引量:1
  • 7PUPO E, LINDNER B, BRADE H, et al. Intact rough- and smooth-form lipopolysaccharides from Escherichia coli sepa- rated by preparative gel electrophoresis exhibit differential bi- ologic activity in human macrophages[J]. FEBS J, 2013, 280 (4) .. 1095-1111. 被引量:1
  • 8NETEA M G, VAN DEUREN M, KULLBERG B J, et al. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?[J]. Trends Immunol, 2002, 23 (3) : 135-139. 被引量:1
  • 9LI Y, WANG Z, CHEN J, et al. Influence of lipid A acyla- tion pattern on membrane permeability and innate immune stimulatlon[J]. Mar Drugs, 2013, 11(9): 3197-3208. 被引量:1
  • 10LEE C C, AVALOS A M, PLOEGH H L. Accessory mole- cules for Toll-like receptors and their function [J]. Nat Rev Immunol, 2012, 12(3) 5 168-179. 被引量:1

二级参考文献13

  • 1Figueiredo M D, Salter C E,Hurley D J, et al. A comparison of e-quine and bovine sera as sources of lipopolysaccharide-binding proteinactivity in equine monocytes incubated with lipopolysaccharide[ J]. VetImmunol Immunopathol,2008, 121 (3/4) : 275 -280. 被引量:1
  • 2Mollnes T E, Christiansen D,Brekke 0 et al. Hypothesis * combinedinhibition of complement and CD14 as treatment regimen to attenuate theinflammatory response[J], Adv Exp Med Biol, 2008 , 632 : 253 - 263. 被引量:1
  • 3Genth-Zotz S, von-Haehling S, Bolger A P, et al. The anti-CD14 anti-body IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure [ J]. Eur J Heart Fail,2006, 8(4): 366 -372. 被引量:1
  • 4Branger J, Florquin S, Knapp S, et al. Lf^-binding protein-deficientmice have an impaired defense against Gram-negative but not Gram-positive pneumonia[ J] . Int Immunol,2004,16(11) : 1605 - 1611. 被引量:1
  • 5Dunzendorfer S, Lee H K, Soldau K, et al. Toll-like receptor4 func-tions intracellularly in human coronary artery endothelial cells ; roles ofLBP and sCD14 in mediating LPS responses[ J]. FASEB J, 2004,18(10): 1117-1119. 被引量:1
  • 6Arana-Mde J, Vallespi M G, Chinea G, et al. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the a-bility of the peptides to block LBP-LPS interaction [ J]. J EndotoxinRes, 2003, 9(5) : 281 -291. 被引量:1
  • 7Marcotorchino J, Romier B, Gouranton E, et al. Lycopene attenuatesLPS-induced TNF-a secretion in macrophages and inflammatorymarkers in adipocytes exposed to macrophage-conditioned media[ J].Mol Nutr Food Res, 2012, 56(5) : 725 -732. 被引量:1
  • 8Higuchi Y, Kawakami S, Oka M, et al. Intravenous administration ofmannosylated cationic liposome/NFkappaB decoy complexes effective-ly prevent LPS-induced cytokine production in a murine liver failuremodel[J]. FEBS Lett, 2006, 580(15): 3706-3714. 被引量:1
  • 9Joh E H, Gu W, Kim D H. Echinocystic acid ameliorates lung in-flammation in mice and alveolar macrophages by inhibiting the bindingof LPS to TLR4 in NF-kB and MAPK pathways [ J]. BiochemPharmacol, 2012, 84(3) : 331 -340. 被引量:1
  • 10Raymondos K, Martin M U, Schmudlach T, et al. Early alveolar andsystemic mediator release in patients at different risks for ARDS aftermultiple trauma[ J]. Injury, 2012,43(2) : 189 - 195. 被引量:1

共引文献1

同被引文献34

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部